1. Home
  2. CTMX vs CARE Comparison

CTMX vs CARE Comparison

Compare CTMX & CARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • CARE
  • Stock Information
  • Founded
  • CTMX 2008
  • CARE 1974
  • Country
  • CTMX United States
  • CARE United States
  • Employees
  • CTMX N/A
  • CARE N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • CARE Major Banks
  • Sector
  • CTMX Health Care
  • CARE Finance
  • Exchange
  • CTMX Nasdaq
  • CARE Nasdaq
  • Market Cap
  • CTMX 349.6M
  • CARE 396.9M
  • IPO Year
  • CTMX 2015
  • CARE N/A
  • Fundamental
  • Price
  • CTMX $1.93
  • CARE $19.78
  • Analyst Decision
  • CTMX Strong Buy
  • CARE Buy
  • Analyst Count
  • CTMX 4
  • CARE 1
  • Target Price
  • CTMX $5.13
  • CARE $22.00
  • AVG Volume (30 Days)
  • CTMX 2.4M
  • CARE 63.4K
  • Earning Date
  • CTMX 11-06-2025
  • CARE 10-23-2025
  • Dividend Yield
  • CTMX N/A
  • CARE N/A
  • EPS Growth
  • CTMX 263.20
  • CARE 154.06
  • EPS
  • CTMX 0.49
  • CARE 1.36
  • Revenue
  • CTMX $141,100,000.00
  • CARE $153,120,000.00
  • Revenue This Year
  • CTMX N/A
  • CARE $10.85
  • Revenue Next Year
  • CTMX N/A
  • CARE $14.12
  • P/E Ratio
  • CTMX $3.98
  • CARE $14.43
  • Revenue Growth
  • CTMX 18.01
  • CARE 21.78
  • 52 Week Low
  • CTMX $0.40
  • CARE $13.61
  • 52 Week High
  • CTMX $3.10
  • CARE $20.53
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 41.17
  • CARE 64.41
  • Support Level
  • CTMX $1.90
  • CARE $19.47
  • Resistance Level
  • CTMX $2.16
  • CARE $20.45
  • Average True Range (ATR)
  • CTMX 0.13
  • CARE 0.48
  • MACD
  • CTMX -0.01
  • CARE -0.04
  • Stochastic Oscillator
  • CTMX 7.50
  • CARE 59.24

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

Share on Social Networks: